# Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer

> **NCT05687851** · PHASE2 · RECRUITING · sponsor: **Chongqing University Cancer Hospital** · enrollment: 33 (estimated)

## Conditions studied

- Locally Advanced Cervical Cancer

## Interventions

- **DRUG:** Cadonilimab（AK104）
- **RADIATION:** EBRT
- **RADIATION:** BT

## Key facts

- **NCT ID:** NCT05687851
- **Lead sponsor:** Chongqing University Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-29
- **Primary completion:** 2024-12-30
- **Final completion:** 2026-12
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05687851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05687851, "Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT05687851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*